Reclaim Your Mind & Sleep with Jim Poole | CEO of NuCalm

In this episode, Jim Poole, CEO of NuCalm, shares how neuroscience can help you manage stress, improve sleep, and reclaim control of your mental state—without drugs or side effects. We explore the science behind NuCalm, its applications for peak performance, and insights from Poole's decades of experience in healthcare, biotech, and global business strategy. Jim Poole says "The human race appears to be in a race to erase the human race." And at a time when "many people seem to have lost control of their lives," NuCalm is the perfect remedy, argues Poole, the visionary CEO behind the stress management technology. "We have a tireless passion for helping people reclaim control of their lives,' says Poole. "And we can do it with the world's most powerful neuroscience. We have a culture of service. We don't serve for reciprocity or credit, we serve because we want to, we can, and we love to. It's our mission and it's our purpose and we will leave an indelible legacy on the human condition." NuCalm is a unique, patented technology that's clinically proven to lower stress and improve sleep quality. It guides brain wave function reliably, safely, and effectively, with no drugs or side effects, using physics, mathematics, and algorithms in neuroacoustic software underneath music. Poole, 55, is an accomplished business executive with extensive experience in the healthcare, biotechnology, medical, financial services, market research, and IT industries. Since 2009 he has managed the strategic direction and ongoing operations of NuCalm, a neuroscience company with an expertise in evidence-based personalized wellness and performance. NuCalm stands alone as a pioneer in neuroscience that provides humans with the power to change their mental state on demand, without drugs or side effects.  In July 2015, the U.S. Patent Office granted NuCalm the first and only patent for "Systems and Methods for Balancing and Maintaining the Health of the Human Autonomic Nervous System." In August 2021, the U.S. Patent Office granted NuCalm the first and only patent for "Methods and devices for applying dynamic, non-linear oscillations and vibrations to elicit a physiological state change in humans." Poole has successfully launched global products, managed growth strategies, and optimized business operations for both large and small organizations. Prior to joining NuCalm, he founded Focused Evolution, a global management strategy consulting firm. As Managing Partner, Poole oversaw mergers and acquisitions, due diligence, and growth strategies for venture capital and private equity firms. Focused Evolution managed the largest private equity acquisition in the history of the dental industry for Credit Suisse DLJ Merchant Banking Partners in 2007 and 2008. Poole has lectured on applied neuropsychobiology, the human stress response, sleep and recovery, brain wave management, and business strategies across the globe, from the Royal College of Physicians in London to the 20th Annual Congress for Brain Mapping and Therapeutics in Los Angeles, from Beijing to St. Petersburg to Parliament to the Pentagon and Quantico to the Toronto Film Festival and the Consumer Electronics Show, the NFL Combine and the Super Bowl, across Europe, the United States, Canada, and India. NuCalm has been featured in The Wall Street Journal, New York Times, FORBES, Access Hollywood, NASDAQ, MSNBC, CBS, the TODAY Show, and more.   Watch and learn more here! Want 15% off for LIFE on NuCalm - use the code KATIE at checkout. https://nucalm.com/ Stay connected: https://www.chonacas.com/links/ Business: https://www.linkedin.com/in/katiechonacas/